MASON SIDDIQUI: Open Payments
NPI 1447927207 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 77 payments from 32 companies in 2025. Trend: 2023 $870 · 2024 $1,978 · 2025 $1,737
Food & beverage: $1,737
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $232 |
| PFIZER INC. | 6 | $114 |
| Merck Sharp & Dohme LLC | 4 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Janssen Biotech, Inc. | 4 | $96 |
| ABBVIE INC. | 5 | $94 |
| Lilly USA, LLC | 3 | $81 |
| Blueprint Medicines Corporation | 2 | $76 |
| Incyte Corporation | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
Products named: Enhertu, KEYTRUDA, EPKINLY, VERZENIO, AYVAKIT, Zoladex, IBRANCE, Orserdu.
Industry payments across MS — which companies pay providers there.
